درمان ضد انعقاد زیرپتویمالی در بیماران ژاپنی با فیبریلاسیون دهلیزی بدون غربالگری دریافت وارفارین برای پیشگیری از سکته مغزی

In this EMR-based clinical study, patients who switched to DOACs had both poor or inadequate PT-INR control and higher risk factors of stroke. Many patients receiving warfarin did not achieve sufficient PT-INR therapeutic range. DOACs could be recommended in Japanese patients with NVAF with inadequate PT-INR control and increased risk of stroke.